Paid Clinical Trials in Midland, MI
As of July 2026, 38 paid clinical trials are recruiting in Midland, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Midland offers studies at sites including MyMichigan Medical Center Midland for conditions such as Breast Cancer, Breast Carcinoma, Malignant Solid Neoplasm, Melanoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Midland
Trials by drug in Midland
Filter results
36 clinical trials
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
The ArtixASCEND Study
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Family Communications After Genetic Testing
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Mobile Health for Adherence in Breast Cancer Patients
E-Mindfulness Approaches for Living After Breast Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Top Research Study Locations in Midland
Researchers run research studies in Midland, MI at 11 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MyMichigan Medical Center Midland | Breast Cancer, Breast Carcinoma, Malignant Solid Neoplasm | 27 |
| Abcentra Investigational Site | Acute Coronary Syndromes, Atherosclerotic Coronary Vascular Disease, Coronary Arterial Disease (CAD) | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Mid-Michigan Eye Care | Low Vision, Low Vision Aids | 1 |
| MidMichigan OB-GYN | Pregnancy, Pregnancy Outcomes, Pregnancy, Complications | 1 |
| MyMichigan Dermatologic Oncology | Cutaneous Squamous Cell Carcinoma (CSCC) | 1 |
| MyMichigan Health | Acute Lower Limb Arterial Occlusion | 1 |
| MyMichigan Medical Center | Deep Venous Thrombosis, Post-Thrombotic Syndrome, Venous Thromboembolism | 1 |
| MyMichigan Medical Center - Midland | Acute Myocardial Infarction | 1 |
| MyMichigan Medical Center Midland - Clinical Research Department | Cardiovascular Disease | 1 |
| Mymichigan Med Ctr Midland | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Midland (2026)
Recruiting trials in Midland grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (18 active studies)
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · Alliance for Clinical Trials in Oncology
Cardiovascular (5 active studies)
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Common conditions studied in Midland
- Breast Cancer (2 active studies)
- Breast Carcinoma (2 active studies)
- Malignant Solid Neoplasm (2 active studies)
- Melanoma (2 active studies)
- RISS Stage I Plasma Cell Myeloma (2 active studies)
- RISS Stage II Plasma Cell Myeloma (2 active studies)
Leading research sponsors in Midland
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
- SWOG Cancer Research Network
- NRG Oncology
- Inari Medical
Frequently asked questions
How many paid clinical trials are currently recruiting in Midland?
There are approximately 38 recruiting clinical trials in Midland, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Midland pay participants?
Most recruiting trials in Midland compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Midland?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Midland?
The most common conditions under active study in Midland include Breast Cancer (2), Breast Carcinoma (2), Malignant Solid Neoplasm (2), Melanoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Midland?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Midland on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Midland?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Midland?
Recruiting research sites in Midland include MyMichigan Medical Center Midland, Abcentra Investigational Site, Clinical Trial Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Midland right now?
The largest active categories in Midland are Cancer & tumors (18), Cardiovascular (5), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.